ES2074067T3 - Piperidinil bencimidazoles como antihistaminicos. - Google Patents

Piperidinil bencimidazoles como antihistaminicos.

Info

Publication number
ES2074067T3
ES2074067T3 ES89118987T ES89118987T ES2074067T3 ES 2074067 T3 ES2074067 T3 ES 2074067T3 ES 89118987 T ES89118987 T ES 89118987T ES 89118987 T ES89118987 T ES 89118987T ES 2074067 T3 ES2074067 T3 ES 2074067T3
Authority
ES
Spain
Prior art keywords
represented
antihistamines
hydrogen
bencimidazoles
piperidinil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89118987T
Other languages
English (en)
Inventor
Albert A Carr
John M Kane
Hsien C Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2074067T3 publication Critical patent/ES2074067T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

SE PRESENTAN ANTIHISTAMINOS DE LA FORMULA (I) EN LA QUE Y SE REPRESENTA POR CO O CHOH, M ES UN ENTERO ENTRE 1 Y 2; R SE REPRESENTA POR UN ALKIL, ALKOXIDO, HALOGENO, HIDROXIDO E HIDROGENO, X SE REPRESENTA POR HIDROGENO, COOR2 EN DONDE R2 SE REPRESENTA POR ALKIL, O X ES UN RADICAL FENIL ALKILENO DE LA FORMULA (II), EN DONDE T SE REPRESENTA POR CHOH, CO, O O UN ENLACE DIRECTO; R1 SE REPRESENTA POR ALKIL, ALKOXIDO, HALOGENO, HIDROXIDO, 2,2 ACIDO DIMETIL ETANOICO E HIDROGENO; N ES UN ENTERO DE 1 A 5; O UNAS SALES FARMACEUTICAMENTE ACEPTABLES DE LAS MISMAS.
ES89118987T 1988-10-13 1989-10-12 Piperidinil bencimidazoles como antihistaminicos. Expired - Lifetime ES2074067T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/256,959 US4908372A (en) 1988-10-13 1988-10-13 Antihistaminic piperidinyl benzimidazoles

Publications (1)

Publication Number Publication Date
ES2074067T3 true ES2074067T3 (es) 1995-09-01

Family

ID=22974308

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89118987T Expired - Lifetime ES2074067T3 (es) 1988-10-13 1989-10-12 Piperidinil bencimidazoles como antihistaminicos.

Country Status (20)

Country Link
US (1) US4908372A (es)
EP (1) EP0363963B1 (es)
JP (1) JP2867151B2 (es)
KR (1) KR0157046B1 (es)
CN (1) CN1028103C (es)
AR (1) AR248018A1 (es)
AT (1) ATE121741T1 (es)
AU (1) AU619601B2 (es)
CA (1) CA2000468C (es)
DE (1) DE68922366T2 (es)
DK (1) DK506189A (es)
ES (1) ES2074067T3 (es)
FI (1) FI894834A0 (es)
HU (1) HU203340B (es)
IE (1) IE66112B1 (es)
IL (1) IL91952A (es)
NO (1) NO894086L (es)
NZ (1) NZ230956A (es)
PT (1) PT91968B (es)
ZA (1) ZA897676B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022451C (en) * 1989-08-03 2001-01-23 Albert Anthony Carr Anti-psychotic piperidynl benzimidazole compounds
AU8506791A (en) * 1990-10-01 1992-04-28 Janssen Pharmaceutica N.V. Novel 4-piperidinylcarbonyl derivatives
FR2668150B1 (fr) * 1990-10-17 1994-11-18 Theramex Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
CA2097317C (en) * 1990-12-14 2002-02-12 Albert A. Carr Antiallergic piperdinyl benzimidazoles
TW263504B (es) * 1991-10-03 1995-11-21 Pfizer
TW231291B (es) * 1992-01-09 1994-10-01 Janssen Pharmaceutica Nv
NZ249286A (en) * 1992-02-13 1996-02-27 Merrell Dow Pharma Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions
NZ292683A (en) 1994-08-25 1998-07-28 Merrell Pharma Inc Piperidine derivatives
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
JP2000507269A (ja) * 1996-03-15 2000-06-13 イーライ・リリー・アンド・カンパニー 一般かぜまたはアレルギー性鼻炎の処置方法
US5869497A (en) * 1996-03-15 1999-02-09 Eli Lilly And Company Method of treating or ameliorating the symptoms of common cold or allergic rhinitis
ES2291293T3 (es) * 2000-02-29 2008-03-01 Mitsubishi Pharma Corporation Nuevos derivados amida ciclicos.
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2006042150A1 (en) * 2004-10-07 2006-04-20 Vitae Pharmaceuticals, Inc. Diaminoalkane aspartic protease inhibitors
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
TWI411607B (zh) * 2005-11-14 2013-10-11 Vitae Pharmaceuticals Inc 天門冬胺酸蛋白酶抑制劑
CL2007002689A1 (es) * 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EP2081927B1 (en) * 2006-09-18 2011-08-17 Vitae Pharmaceuticals, Inc. Piperidine derivatives as renin inhibitors
EP2167609A1 (en) * 2007-06-20 2010-03-31 Vitae Pharmaceuticals, Inc. Renin inhibitors
EP2170815A2 (en) * 2007-06-20 2010-04-07 Vitae Pharmaceuticals, Inc. Renin inhibitors
US20110160300A1 (en) * 2008-06-20 2011-06-30 Marlys Hammond Renin Inhibitors and Methods of Use Thereof
WO2009158377A1 (en) * 2008-06-26 2009-12-30 Smith Kline Beecham Corporation Salts of methyl 2-((r))-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
AR077692A1 (es) * 2009-08-06 2011-09-14 Vitae Pharmaceuticals Inc Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
EP2447263A1 (en) 2010-09-27 2012-05-02 Bioprojet Benzazole derivatives as histamine H4 receptor ligands
CN104428293B (zh) 2012-06-11 2018-06-08 Ucb生物制药私人有限公司 调节TNFα的苯并咪唑类
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
CA2022451C (en) * 1989-08-03 2001-01-23 Albert Anthony Carr Anti-psychotic piperidynl benzimidazole compounds

Also Published As

Publication number Publication date
IE893294L (en) 1990-04-13
EP0363963B1 (en) 1995-04-26
HUT51613A (en) 1990-05-28
CN1028103C (zh) 1995-04-05
IL91952A (en) 1994-06-24
FI894834A0 (fi) 1989-10-12
KR900006318A (ko) 1990-05-07
HU895305D0 (en) 1990-01-28
EP0363963A1 (en) 1990-04-18
AU619601B2 (en) 1992-01-30
PT91968A (pt) 1990-04-30
NZ230956A (en) 1991-03-26
NO894086L (no) 1990-04-17
ATE121741T1 (de) 1995-05-15
JP2867151B2 (ja) 1999-03-08
DK506189D0 (da) 1989-10-12
AR248018A1 (es) 1995-05-31
DE68922366T2 (de) 1995-09-28
AU4273589A (en) 1990-04-26
JPH02134377A (ja) 1990-05-23
KR0157046B1 (ko) 1998-11-16
IL91952A0 (en) 1990-06-10
CN1041940A (zh) 1990-05-09
NO894086D0 (no) 1989-10-12
US4908372A (en) 1990-03-13
HU203340B (en) 1991-07-29
DK506189A (da) 1990-04-14
ZA897676B (en) 1990-07-25
CA2000468A1 (en) 1990-04-13
DE68922366D1 (de) 1995-06-01
PT91968B (pt) 1995-05-31
CA2000468C (en) 2000-03-21
IE66112B1 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
ES2074067T3 (es) Piperidinil bencimidazoles como antihistaminicos.
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
ATE95992T1 (de) Sauerstoffabsorptionsmittel.
SE8404019L (sv) Oftalmiska antiinflammatoriska medel
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
DE3381850D1 (de) Pharmazeutische zusammensetzung.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
ES2054231T3 (es) Procedimiento para preparar oxido de estireno.
FI955830A (fi) Menetelmä alkyylihalogeenidifluoriasetaattien valmistamiseksi
FI915979A (fi) Fenylalkylaminoalkylfoereningar samt foerfaranden foer deras framstaellning och laekemedel som innehaoller dessa foereningar.
RU1771475C (ru) Способ получени 6-бензилоксизамещенных изопропиловых эфиров @ -карболин-3-карбоновой кислоты
ATE25519T1 (de) Benzo(f)chinolinderivate.
GB993255A (en) Process for the production of dibenzoazepine derivatives
SU1205522A1 (ru) 2,4,6-три-трет.бутил-2,5-циклогексадиенон-ил-4-(1,1-диэтокси-1-этил)перокс ид в качестве инициатора свободнорадикальных превращений алкилортоформиатов
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
ES2073606T3 (es) Procedimiento para la preparacion de derivados de acido beta-resorcilico.
DE3485884D1 (de) Organo-borat zusammensetzungen und deren anwendung in schmiermitteln.
SE8104583L (sv) Polyhalogenerade omettade monomerestrat samt forfarande for framstellning derav

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 363963

Country of ref document: ES